Loading…
Reported covered position: Chief of Staff - Rep. Loretta Sanchez
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military personnel; S. 3988/H.R. 6835, Veterans Spinal Trauma Access to New Devices (STAND) Act
Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military personnel; Issues related to the implementation of Public Law No: 118-50, Making emergency supplemental appropriations for the fiscal year ending September 30, 2024, and for other purposes S. 3988/H.R. 6835, Veterans Spinal Trauma Access to New Devices (STAND) Act
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ONWARD MEDICAL, INC. via ALPEX INTERNATIONAL, LLC
2026 · third_quarter · Q3
Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military personnel; S. 3988/H.R. 6835, Veterans Spinal Trauma Access to New Devices (STAND) Act
Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military and civilian personnel; S. 3988/H.R. 6835, Veterans Spinal Trauma Access to New Devices (STAND) Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
| CONGAREE RIVER GROUP LLC (OBO WEJO DATA SERVICES, INC.) |
| 6 |
| 2022 |
Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military and civilian personnel; Issues related to the implementation of Public Law No: 118-50, Making emergency supplemental appropriations for the fiscal year ending September 30, 2024, and for other purposes; S. 3988/H.R. 6835, Veterans Spinal Trauma Access to New Devices (STAND) Act
Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military and civilian personnel; S. 3988/H.R. 6835, Veterans Spinal Trauma Access to New Devices (STAND) Act
Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military personnel; S. 3988/H.R. 6835, Veterans Spinal Trauma Access to New Devices (STAND) Act
Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military personnel; Issues related to the implementation of Public Law No: 118-50, Making emergency supplemental appropriations for the fiscal year ending September 30, 2024, and for other purposes S. 3988/H.R. 6835, Veterans Spinal Trauma Access to New Devices (STAND) Act
Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military and civilian personnel; Issues related to the implementation of Public Law No: 118-50, Making emergency supplemental appropriations for the fiscal year ending September 30, 2024, and for other purposes; S. 3988/H.R. 6835, Veterans Spinal Trauma Access to New Devices (STAND) Act
Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military and civilian personnel; S. 3988/H.R. 6835, Veterans Spinal Trauma Access to New Devices (STAND) Act
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: ONWARD MEDICAL, INC. · Firm: ALPEX INTERNATIONAL, LLC
Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military and civilian personnel H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (PL 119-4)
Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026
Client: ONWARD MEDICAL, INC. · Firm: ALPEX INTERNATIONAL, LLC
Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military and civilian personnel; H.R. 3944, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026 - issues related to Veterans
GUARD Veterans’ Health Care Act
Client: ONWARD MEDICAL, INC. · Firm: ALPEX INTERNATIONAL, LLC
Programs administered by the Department of Veterans Affairs Office of Research & Development, and the Office of Clinical Science Research and Development; Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military personnel; H.R. 4077, GUARD Veterans Health Care Act; H.R. 740, Veterans ACCESS Act of 2025
Programs administered by the Department of Veterans Affairs Office of Research & Development, and the Office of Clinical Science Research and Development; Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military personnel; H.R. 4077, GUARD Veterans Health Care Act; H.R. 740, Veterans ACCESS Act of 2025
Consolidated Appropriations Act, 2023
Client: NIKOLA CORPORATION · Firm: ALPEX INTERNATIONAL, LLC
Renewable fuel standard DOE funding for programs related to advanced vehicle technology and hydrogen research and development H.R. 2617, Consolidated Appropriations Act, 2023
Consolidated Appropriations Act, 2023
Client: ONWARD MEDICAL, INC. · Firm: ALPEX INTERNATIONAL, LLC
Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military personnel H.R. 2617, Consolidated Appropriations Act, 2023
Tax credits impacting commercial zero-emission vehicles and hydrogen production - commercial EV tax credit, alternative refueling infrastructure tax credit, hydrogen production tax credit, carbon sequestration tax credit H.R. 5376, Build Back Better Act
Tax credits impacting commercial zero-emission vehicles and hydrogen production - commercial EV tax credit, alternative refueling infrastructure tax credit, hydrogen production tax credit, carbon sequestration tax credit H.R. 5376, Build Back Better Act
Tax credits impacting commercial zero-emission vehicles and hydrogen production - commercial EV tax credit, alternative refueling infrastructure tax credit, hydrogen production tax credit, carbon sequestration tax credit H.R. 5376, Inflation Reduction Act
Infrastructure Investment and Jobs Act
Client: NIKOLA CORPORATION · Firm: ALPEX INTERNATIONAL, LLC
Renewable fuel standard DOE funding for programs related to advanced vehicle technology and hydrogen research and development H.R. 3684, Infrastructure Investment and Jobs Act
Infrastructure Investment and Jobs Act
Client: NIKOLA CORPORATION · Firm: ALPEX INTERNATIONAL, LLC
Issues related to the development and manufacture of zero emission vehicles; Issues related to fueling station infrastructure; FHWA weight and safety issues; Port event for delivery of battery-electric heavy-duty vehicles; H.R. 3684, Infrastructure Investment and Jobs Act
Tax credits impacting commercial zero-emission vehicles and hydrogen production - commercial EV tax credit, alternative refueling infrastructure tax credit, hydrogen production tax credit, carbon sequestration tax credit H.R. 5376, Build Back Better Act
ONWARD MEDICAL, INC. via ALPEX INTERNATIONAL, LLC
2026 · second_quarter · Q2
Issues related to the "Nairobi Protocol" tariff treatment that grants duty-free importation status to educational, scientific, and cultural materials - specifically expanding coverage to include articles for handicapped persons - 1121 of the Omnibus Trade and Competitiveness Act of 1988 (Pub. L. 100-418, 102 Stat. 1107) and Presidential Proclamation 5978 (54 FR 21187).
Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military and civilian personnel; Issues related to the implementation of Public Law No: 118-50, Making emergency supplemental appropriations for the fiscal year ending September 30, 2024, and for other purposes; S. 3988/H.R. 6835, Veterans Spinal Trauma Access to New Devices (STAND) Act
Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military personnel; Issues related to the implementation of Public Law No: 118-50, Making emergency supplemental appropriations for the fiscal year ending September 30, 2024, and for other purposes S. 3988/H.R. 6835, Veterans Spinal Trauma Access to New Devices (STAND) Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ONWARD MEDICAL, INC. via ALPEX INTERNATIONAL, LLC
2026 · first_quarter · Q1
Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military and civilian personnel; Issues related to the implementation of Public Law No: 118-50, Making emergency supplemental appropriations for the fiscal year ending September 30, 2024, and for other purposes
Issues related to the "Nairobi Protocol" tariff treatment that grants duty-free importation status to educational, scientific, and cultural materials - specifically expanding coverage to include articles for handicapped persons - 1121 of the Omnibus Trade and Competitiveness Act of 1988 (Pub. L. 100-418, 102 Stat. 1107) and Presidential Proclamation 5978 (54 FR 21187).
Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military personnel; Issues related to the implementation of Public Law No: 118-50, Making emergency supplemental appropriations for the fiscal year ending September 30, 2024, and for other purposes
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ONWARD MEDICAL, INC. via ALPEX INTERNATIONAL, LLC
2025 · fourth_quarter · Q4
Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military personnel; Issues related to the implementation of Public Law No: 118-50, Making emergency supplemental appropriations for the fiscal year ending September 30, 2024, and for other purposes; Veterans STAND Act
Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military and civilian personnel; Issues related to the implementation of Public Law No: 118-50, Making emergency supplemental appropriations for the fiscal year ending September 30, 2024, and for other purposes
Tariff implications of Executive Branch policies and action
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ONWARD MEDICAL, INC. via ALPEX INTERNATIONAL, LLC
2025 · third_quarter · Q3
Programs administered by the Department of Veterans Affairs Office of Research & Development, and the Office of Clinical Science Research and Development; Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military personnel; H.R. 4077, GUARD Veterans Health Care Act; H.R. 740, Veterans ACCESS Act of 2025
Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military and civilian personnel
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ONWARD MEDICAL, INC. via ALPEX INTERNATIONAL, LLC
2025 · second_quarter · Q2
Programs administered by the Department of Veterans Affairs Office of Research & Development, and the Office of Clinical Science Research and Development; Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military personnel
Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military and civilian personnel; H.R. 3944, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026 - issues related to Veterans
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NIKOLA CORPORATION via ALPEX INTERNATIONAL, LLC
2025 · first_quarter · 1T
Issues related to the development and manufacture of zero emission vehicles; Federal government funding and incentives
Filing targets: Energy, Dept of
ONWARD MEDICAL, INC. via ALPEX INTERNATIONAL, LLC
2025 · first_quarter · Q1
Programs administered by the Department of Veterans Affairs Office of Research & Development, and the Office of Clinical Science Research and Development; Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military personnel
Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military and civilian personnel H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (PL 119-4)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ONWARD MEDICAL, INC. via ALPEX INTERNATIONAL, LLC
2024 · fourth_quarter · Q4
Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military and civilian personnel; Issues related to the implementation of Public Law No: 118-50 (Making emergency supplemental appropriations for the fiscal year ending September 30, 2024, and for other purposes).
Implementation of Consolidated Appropriations Act of 2023 (PL 116-25); Programs administered by the Department of Veterans Affairs Office of Research & Development, and the Office of Clinical Science Research and Development; Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military personnel
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA)
NIKOLA CORPORATION via ALPEX INTERNATIONAL, LLC
2024 · fourth_quarter · Q4
Issues related to the development and manufacture of zero emission vehicles; Federal government funding and incentives
Filing targets: Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), SENATE
ONWARD MEDICAL, INC. via ALPEX INTERNATIONAL, LLC
2024 · third_quarter · Q3
Implementation of Consolidated Appropriations Act of 2023 (PL 116-25); Programs administered by the Department of Veterans Affairs Office of Research & Development, and the Office of Clinical Science Research and Development; Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military personnel
Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military and civilian personnel; Issues related to the implementation of Public Law No: 118-50 (Making emergency supplemental appropriations for the fiscal year ending September 30, 2024, and for other purposes).
Filing targets: SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA)
NIKOLA CORPORATION via ALPEX INTERNATIONAL, LLC
2024 · third_quarter · Q3
Issues related to the development and manufacture of zero emission vehicles; Federal government funding and incentives included in the Infrastructure Investment and Jobs Act (P.L. 117-58) and the Inflation Reduction Act of 2022 (P.L. 117-169) authorized programs
Filing targets: Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT)
ONWARD MEDICAL, INC. via ALPEX INTERNATIONAL, LLC
2024 · second_quarter · Q2
Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military and civilian personnel; Issues related to the implementation of Public Law No: 118-50 (Making emergency supplemental appropriations for the fiscal year ending September 30, 2024, and for other purposes).
Implementation of Consolidated Appropriations Act of 2023 (PL 116-25); Programs administered by the Department of Veterans Affairs Office of Research & Development, and the Office of Clinical Science Research and Development; Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military personnel
Filing targets: SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA)
NIKOLA CORPORATION via ALPEX INTERNATIONAL, LLC
2024 · second_quarter · Q2
Issues related to the development and manufacture of zero emission vehicles; Federal Government vehicle procurement
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
BEYOND PLASTIC, LLC via ALPEX INTERNATIONAL, LLC
2024 · second_quarter · 2T
Issues related to President Biden's Executive Order 14081 - Advancing Biotechnology and Biomanufacturing in the US
Issues related to President Biden's Executive Order 14081 - Advancing Biotechnology and Biomanufacturing in the US
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ONWARD MEDICAL, INC. via ALPEX INTERNATIONAL, LLC
2024 · first_quarter · Q1
Implementation of Consolidated Appropriations Act of 2023 (PL 116-25) and Consolidated Appropriations Act, 2024 (PL 118-42) Programs administered by the Department of Veterans Affairs Office of Research & Development, and the Office of Clinical Science Research and Development Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military personnel
Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military and civilian personnel
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NIKOLA CORPORATION via ALPEX INTERNATIONAL, LLC
2024 · first_quarter · Q1
Issues related to the development and manufacture of zero emission vehicles; Federal Government vehicle procurement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BEYOND PLASTIC, LLC via ALPEX INTERNATIONAL, LLC
2024 · first_quarter · Q1
Issues related to President Biden's Executive Order 14081 - Advancing Biotechnology and Biomanufacturing in the US
Issues related to President Biden's Executive Order 14081 - Advancing Biotechnology and Biomanufacturing in the US
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ONWARD MEDICAL, INC. via ALPEX INTERNATIONAL, LLC
2023 · fourth_quarter · Q4
Implementation of Consolidated Appropriations Act of 2023 (PL 116-25) Programs administered by the Department of Veterans Affairs Office of Research & Development, and the Office of Clinical Science Research and Development Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military personnel
Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military and civilian personnel
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
NIKOLA CORPORATION via ALPEX INTERNATIONAL, LLC
2023 · fourth_quarter · Q4
Issues related to the development and manufacture of zero emission vehicles; Federal Government vehicle procurement
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
BEYOND PLASTIC, LLC via ALPEX INTERNATIONAL, LLC
2023 · fourth_quarter · Q4
Issues related to President Biden's Executive Order 14081 - Advancing Biotechnology and Biomanufacturing in the US
Issues related to President Biden's Executive Order 14081 - Advancing Biotechnology and Biomanufacturing in the US
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, Natl Institute of Standards & Technology (NIST), SENATE
ONWARD MEDICAL, INC. via ALPEX INTERNATIONAL, LLC
2023 · third_quarter · Q3
Implementation of Consolidated Appropriations Act of 2023 (PL 116-25) Programs administered by the Department of Veterans Affairs Office of Research & Development, and the Office of Clinical Science Research and Development Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military personnel
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
NIKOLA CORPORATION via ALPEX INTERNATIONAL, LLC
2023 · third_quarter · Q3
Issues related to the development and manufacture of zero emission vehicles; Federal Government vehicle procurement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BEYOND PLASTIC, LLC via ALPEX INTERNATIONAL, LLC
2023 · third_quarter · Q3
Issues related to President Biden's Executive Order #14081 - Advancing Biotechnology and Biomanufacturing in the US
Issues related to President Biden's Executive Order #14081 - Advancing Biotechnology and Biomanufacturing in the US
Filing targets: Agriculture, Dept of (USDA), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
BEYOND PLASTIC, LLC via ALPEX INTERNATIONAL, LLC
2023 · second_quarter · Q2
Issues related to President Biden's Executive Order #14081 - Advancing Biotechnology and Biomanufacturing in the US
Issues related to President Biden's Executive Order #14081 - Advancing Biotechnology and Biomanufacturing in the US
Filing targets: Agriculture, Dept of (USDA), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
ONWARD MEDICAL, INC. via ALPEX INTERNATIONAL, LLC
2023 · second_quarter · Q2
Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military personnel; Implementation of Consolidated Appropriations Act of 2023 (PL 116-25)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
NIKOLA CORPORATION via ALPEX INTERNATIONAL, LLC
2023 · second_quarter · Q2
Issues related to the development and manufacture of zero emission vehicles; Federal Government vehicle procurement
Filing targets: Defense, Dept of (DOD), General Services Administration (GSA), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), SENATE
BEYOND PLASTIC, LLC via ALPEX INTERNATIONAL, LLC
2023 · second_quarter · RR
Issues related to biotechnology and biomanufacturing
Issues related to biotechnology and biomanufacturing
ONWARD MEDICAL, INC. via ALPEX INTERNATIONAL, LLC
2023 · first_quarter · Q1
Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military personnel; implementation of Consolidated Appropriations Act of 2023 (PL 116-25)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
NIKOLA CORPORATION via ALPEX INTERNATIONAL, LLC
2023 · first_quarter · Q1
Issues related to the development and manufacture of zero emission vehicles; Issues related to fueling station infrastructure; FHWA weight and safety issues; Federal Government vehicle procurement
Filing targets: Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Interior, Dept of (DOI), SENATE, Transportation, Dept of (DOT)
DB GROUP AMERICA, LTD via ALPEX INTERNATIONAL, LLC
2023 · first_quarter · 1T
Issues related to e-commerce and trade, including low-value shipments entering the US; Warehouse permit processing by the Department of Homeland Security
Filing targets: Homeland Security, Dept of (DHS)
CONGAREE RIVER GROUP LLC (OBO WEJO DATA SERVICES, INC.) via ALPEX INTERNATIONAL, LLC
2022 · third_quarter · 3A
Issues related to data privacy
Issues related to data privacy
Filing targets: SENATE, Transportation, Dept of (DOT)
CONGAREE RIVER GROUP LLC (OBO WEJO DATA SERVICES, INC.) via ALPEX INTERNATIONAL, LLC
2022 · third_quarter · 3A
Issues related to data privacy
Issues related to data privacy
Filing targets: SENATE, Transportation, Dept of (DOT)
ONWARD MEDICAL, INC. via ALPEX INTERNATIONAL, LLC
2022 · fourth_quarter · Q4
Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military personnel H.R. 2617, Consolidated Appropriations Act, 2023
Filing targets: SENATE
NIKOLA CORPORATION via ALPEX INTERNATIONAL, LLC
2022 · fourth_quarter · Q4
Issues related to the development and manufacture of zero emission vehicles; Issues related to fueling station infrastructure; FHWA weight and safety issues
Renewable fuel standard DOE funding for programs related to advanced vehicle technology and hydrogen research and development H.R. 2617, Consolidated Appropriations Act, 2023
Tax credits impacting commercial zero-emission vehicles and hydrogen production - commercial EV tax credit, alternative refueling infrastructure tax credit, hydrogen production tax credit, carbon sequestration tax credit Inflation Reduction Act
DB GROUP AMERICA, LTD via ALPEX INTERNATIONAL, LLC
2022 · fourth_quarter · Q4
Issues related to e-commerce and trade, including low-value shipments entering the US
CONGAREE RIVER GROUP LLC (OBO WEJO DATA SERVICES, INC.) via ALPEX INTERNATIONAL, LLC
2022 · third_quarter · Q3
Issues related to data privacy
Issues related to data privacy
Filing targets: HOUSE OF REPRESENTATIVES, Natl Highway Traffic Safety Administration (NHTSA), SENATE, Transportation, Dept of (DOT)
ONWARD MEDICAL, INC. via ALPEX INTERNATIONAL, LLC
2022 · third_quarter · Q3
Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military personnel
Filing targets: HOUSE OF REPRESENTATIVES
NIKOLA CORPORATION via ALPEX INTERNATIONAL, LLC
2022 · third_quarter · Q3
Tax credits impacting commercial zero-emission vehicles and hydrogen production - commercial EV tax credit, alternative refueling infrastructure tax credit, hydrogen production tax credit, carbon sequestration tax credit H.R. 5376, Inflation Reduction Act
Issues related to the development and manufacture of zero emission vehicles; Issues related to fueling station infrastructure; FHWA weight and safety issues
Renewable fuel standard DOE funding for programs related to advanced vehicle technology and hydrogen research and development
DB GROUP AMERICA, LTD via ALPEX INTERNATIONAL, LLC
2022 · third_quarter · Q3
Issues related to e-commerce and trade, including low-value shipments entering the US
ONWARD MEDICAL, INC. via ALPEX INTERNATIONAL, LLC
2022 · second_quarter · Q2
Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military personnel
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NIKOLA CORPORATION via ALPEX INTERNATIONAL, LLC
2022 · second_quarter · Q2
Tax credits impacting commercial zero-emission vehicles and hydrogen production - commercial EV tax credit, alternative refueling infrastructure tax credit, hydrogen production tax credit, carbon sequestration tax credit H.R. 5376, Build Back Better Act
Issues related to the development and manufacture of zero emission vehicles; Issues related to fueling station infrastructure; FHWA weight and safety issues
Renewable fuel standard DOE funding for programs related to advanced vehicle technology and hydrogen research and development
DB GROUP AMERICA, LTD via ALPEX INTERNATIONAL, LLC
2022 · second_quarter · Q2
Issues related to e-commerce and trade, including low-value shipments entering the US
Filing targets: HOUSE OF REPRESENTATIVES
CONGAREE RIVER GROUP LLC (OBO WEJO DATA SERVICES, INC.) via ALPEX INTERNATIONAL, LLC
2022 · second_quarter · Q2
Issues related to data privacy
Issues related to data privacy
Filing targets: HOUSE OF REPRESENTATIVES, Natl Highway Traffic Safety Administration (NHTSA), SENATE, Transportation, Dept of (DOT)
CONGAREE RIVER GROUP LLC (OBO WEJO DATA SERVICES, INC.) via ALPEX INTERNATIONAL, LLC
2022 · first_quarter · Q1
Issues related to data privacy
Issues related to data privacy
NIKOLA CORPORATION via ALPEX INTERNATIONAL, LLC
2022 · first_quarter · Q1
Tax credits impacting commercial zero-emission vehicles and hydrogen production - commercial EV tax credit, alternative refueling infrastructure tax credit, hydrogen production tax credit, carbon sequestration tax credit H.R. 5376, Build Back Better Act
Issues related to the development and manufacture of zero emission vehicles; Issues related to fueling station infrastructure; FHWA weight and safety issues
Renewable fuel standard DOE funding for programs related to advanced vehicle technology and hydrogen research and development
CONGAREE RIVER GROUP LLC (OBO WEJO DATA SERVICES, INC.) via ALPEX INTERNATIONAL, LLC
2022 · first_quarter · RR
Issues related to data privacy
Issues related to data privacy
ONWARD MEDICAL, INC. via ALPEX INTERNATIONAL, LLC
2022 · first_quarter · Q1
Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military personnel
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
DB GROUP AMERICA, LTD via ALPEX INTERNATIONAL, LLC
2022 · first_quarter · Q1
Issues related to e-commerce and trade, including low-value shipments entering the US
Filing targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS)
ONWARD MEDICAL, INC. via ALPEX INTERNATIONAL, LLC
2021 · fourth_quarter · Q4
Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military personnel
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
DB GROUP AMERICA, LTD via ALPEX INTERNATIONAL, LLC
2021 · fourth_quarter · Q4
Issues related to e-commerce and trade, including low-value shipments entering the US
Filing targets: HOUSE OF REPRESENTATIVES
FANTIC MOTOR S.P.A. via ALPEX INTERNATIONAL, LLC
2021 · third_quarter · 3T
Issues related to market access
NIKOLA CORPORATION via ALPEX INTERNATIONAL, LLC
2021 · fourth_quarter · Q4
Tax credits impacting commercial zero-emission vehicles and hydrogen production - commercial EV tax credit, alternative refueling infrastructure tax credit, hydrogen production tax credit, carbon sequestration tax credit H.R. 5376, Build Back Better Act
Issues related to the development and manufacture of zero emission vehicles; Issues related to fueling station infrastructure; FHWA weight and safety issues; Port event for delivery of battery-electric heavy-duty vehicles; H.R. 3684, Infrastructure Investment and Jobs Act
Renewable fuel standard DOE funding for programs related to advanced vehicle technology and hydrogen research and development H.R. 3684, Infrastructure Investment and Jobs Act
ONWARD MEDICAL, INC. via ALPEX INTERNATIONAL, LLC
2021 · third_quarter · Q3
Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military personnel
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
NIKOLA CORPORATION via ALPEX INTERNATIONAL, LLC
2021 · third_quarter · Q3
Issues related to the development and manufacture of zero emission vehicles; Issues related to fueling station infrastructure
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
DB GROUP AMERICA, LTD via ALPEX INTERNATIONAL, LLC
2021 · third_quarter · Q3
Issues related to e-commerce and trade, including low-value shipments entering the US
Filing targets: HOUSE OF REPRESENTATIVES
FANTIC MOTOR S.P.A. via ALPEX INTERNATIONAL, LLC
2021 · third_quarter · Q3
Issues related to market access
ONWARD MEDICAL, INC. via ALPEX INTERNATIONAL, LLC
2021 · third_quarter · RR
Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military personnel
GARMONT INTERNATIONAL S.R.L. via ALPEX INTERNATIONAL, LLC
2021 · second_quarter · 2T
Issues related to market access and agency procurement
Filing targets: HOUSE OF REPRESENTATIVES
NIKOLA CORPORATION via ALPEX INTERNATIONAL, LLC
2021 · second_quarter · Q2
Issues related to the development and manufacture of zero emission vehicles; Issues related to fueling station infrastructure
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
FANTIC MOTOR S.P.A. via ALPEX INTERNATIONAL, LLC
2021 · second_quarter · Q2
Issues related to market access
DB GROUP AMERICA, LTD via ALPEX INTERNATIONAL, LLC
2021 · second_quarter · Q2
Issues related to e-commerce and trade, including low-value shipments entering the US
Filing targets: HOUSE OF REPRESENTATIVES
NIKOLA CORPORATION via ALPEX INTERNATIONAL, LLC
2021 · second_quarter · RR
Issues related to the development and manufacture of zero emission vehicles; issues related to fueling station infrastructure
Issues related to the development and manufacture of zero emission vehicles; issues related to fueling station infrastructure
Issues related to the development and manufacture of zero emission vehicles; issues related to fueling station infrastructure
GARMONT INTERNATIONAL S.R.L. via ALPEX INTERNATIONAL, LLC
2021 · first_quarter · Q1
Issues related to market access and agency procurement
Filing targets: HOUSE OF REPRESENTATIVES
FANTIC MOTOR S.P.A. via ALPEX INTERNATIONAL, LLC
2021 · first_quarter · Q1
Issues related to market access
DB GROUP AMERICA, LTD via ALPEX INTERNATIONAL, LLC
2021 · first_quarter · Q1
Issues related to e-commerce and trade, including low-value shipments entering the US
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DB GROUP AMERICA, LTD via ALPEX INTERNATIONAL, LLC
2020 · fourth_quarter · Q4
Issues related to e-commerce and trade, including low-value shipments entering the US
Filing targets: HOUSE OF REPRESENTATIVES
FANTIC MOTOR S.P.A. via ALPEX INTERNATIONAL, LLC
2020 · fourth_quarter · Q4
Issues related to market access
GARMONT INTERNATIONAL S.R.L. via ALPEX INTERNATIONAL, LLC
2020 · fourth_quarter · Q4
Issues related to market access and agency procurement
GARMONT INTERNATIONAL S.R.L. via ALPEX INTERNATIONAL, LLC
2020 · third_quarter · Q3
Issues related to market access and agency procurement
Filing targets: HOUSE OF REPRESENTATIVES
FANTIC MOTOR S.P.A. via ALPEX INTERNATIONAL, LLC
2020 · third_quarter · Q3
Issues related to market and banking access
Filing targets: HOUSE OF REPRESENTATIVES
DB GROUP AMERICA, LTD via ALPEX INTERNATIONAL, LLC
2020 · third_quarter · Q3
Issues related to e-commerce and trade, including low-value shipments entering the US
Issues related to e-commerce and trade, including low-value shipments entering the US
Filing targets: HOUSE OF REPRESENTATIVES
DB GROUP AMERICA, LTD via ALPEX INTERNATIONAL, LLC
2020 · third_quarter · RR
Issues related to e-commerce and trade, including low-value shipments entering the US
Issues related to e-commerce and trade, including low-value shipments entering the US
FANTIC MOTOR S.P.A. via ALPEX INTERNATIONAL, LLC
2020 · second_quarter · Q2
Issues related to market and banking access
GARMONT INTERNATIONAL S.R.L. via ALPEX INTERNATIONAL, LLC
2020 · second_quarter · Q2
Issues related to market access and agency procurement
FANTIC MOTOR S.P.A. via ALPEX INTERNATIONAL, LLC
2020 · second_quarter · RR
Issues related to market access, standards for imports of e-bikes, use of e-bikes in national parks and national forests, and regional bank financing, including federal and state tax treatment of e-bike purchases.
Issues related to market access, standards for imports of e-bikes, use of e-bikes in national parks and national forests, and regional bank financing, including federal and state tax treatment of e-bike purchases.
Issues related to market access, standards for imports of e-bikes, use of e-bikes in national parks and national forests, and regional bank financing, including federal and state tax treatment of e-bike purchases.
GARMONT INTERNATIONAL S.R.L. via ALPEX INTERNATIONAL, LLC
2020 · first_quarter · Q1
Issues related to market access and agency procurement
Filing targets: HOUSE OF REPRESENTATIVES
GARMONT INTERNATIONAL S.R.L. via ALPEX INTERNATIONAL, LLC
2020 · first_quarter · RR
Issues related to market access and federal agency procurement
Issues related to market access and federal agency procurement
Issues related to market access and federal agency procurement
Filing targets: Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT), Treasury, Dept of
Filing targets: Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT)
Filing targets: Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT)
Filing targets: Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT)
Filing targets: Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT)
Issues related to market access and federal agency procurement
Issues related to market access and federal agency procurement
Issues related to market access and federal agency procurement